Between 2011 and 2022, the proportion of pediatric care costs related to behavioral health increased from 22.4% to 40.2%, nearly doubling.

Compared with other methods, slow tapering paired with psychological support may be effective for preventing remitted depression relapse.

The FDA has cleared LumosityRx to improve attention function in adults aged 22 to 55 years with primarily inattentive or combined-type ADHD.

The FDA has expanded the approval of Addyi to include the treatment of hypoactive sexual desire disorder in women less than 65 years.

Updated 2024-2025 COVID-19 vaccines provide meaningful protection for children against emergency department and urgent care visits in the US.

Danielle Nicole Larson, MD, discusses the mental health burden on patients with tardive dyskinesia, and considerations for clinicians who manage this condition.

This is a syndicated post stub. Psychiatry Advisor, a trusted source of medical news and feature content for healthcare providers, offers clinicians insight into the latest research to inform clinical ...